活动在阿尔茨海默氏病中的作用
Tsang-Shan Chen1, Ming-Chi Lai2, Wei-Pin Hong3
1Department of Neurology, Tainan Sin-Lau Hospital, Tainan, Taiwan.
American journal of Alzheimer's disease and other dementias
|November 22, 2024
概括
阿尔茨海默病 (AD) 和有共同的联系,发作可能会加剧认知能力下降. 本综述探讨了活动与阿尔茨海默病之间的联系,强调了共同的机制和治疗可能性.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 老年病的医生 老年病的医生
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因.
- 发作越来越被认为是阿尔茨海默病患者常见的并发症.
- 患有的人患痴呆症的风险较高.
研究的目的:
- 审查发作和阿尔茨海默病之间的复杂关系.
- 阐明活动对阿尔茨海默氏症认知衰退的影响.
- 讨论针对这种并发症的潜在治疗策略.
主要方法:
- 实验和临床研究的文献综述.
- 对粉样β和蛋白在过度兴奋性中的作用的数据分析.
- 检查临床观察结果,将发作与加速认知障碍联系起来.
主要成果:
- 实验证据表明,粉样β和蛋白具有发性特性.
- 神经元过度兴奋与阿尔茨海默病的开始有关,并影响粉样蛋白-β比率.
- 临床数据表明,发作加剧了阿兹海默症患者的认知衰退.
结论:
- 活动和AD病变发生之间可能存在双向关系.
- 共同的潜在机制,包括神经元过度兴奋,链接AD和.
- 需要进一步的研究来开发针对阿尔茨海默病和发作的有针对性的治疗方法.
更多相关视频
11:01Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
13.6K
09:49Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
Published on: June 29, 2022
2.4K
相关概念视频
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antiepileptic Drugs: Glutamate Antagonists
283
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
283
Role of Neurotransmitters in Memory
436
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
436
Antiepileptic Drugs: GABAergic Pathway Potentiators
333
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
333
